Moreover, our experiments indicate that NAMPT inhibitor treatment, even at doses without broad side effects, may be counter-therapeutic because of the critical roles for NAMPT induction in supporting pro-inflammatory immune responses against malignant disease, either endogenous or especially in relation to cancer immunotherapies. Here, NAMPT is linked to cancer.